Paper36960492
NRF1 Regulates the Epithelial Mesenchymal Transition of Breast Cancer by Modulating ROS Homeostasis.
Sun L and 8 others. Technol Cancer Res Treat, 2023. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. NRF1 Regulates the Epithelial Mesenchymal Transition of Breast Cancer by Modulating ROS Homeostasis. Papers, record 36960492. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36960492
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- NRF1 Regulates the Epithelial Mesenchymal Transition of Breast Cancer by Modulating ROS Homeostasis.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Epithelial-Mesenchymal Transition | Major topic |
| Nuclear Respiratory Factor 1 | Major topic |
| Anoikis | Major topic |
| Humans | |
| Female | |
| Cell Line, Tumor | |
| Oxidative Phosphorylation | |
| Homeostasis | |
| Adenosine Triphosphate | |
| Mitochondria | |
| Membrane Potential, Mitochondrial | |
| Reactive Oxygen Species |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27915969 | Anoikis and EMT: Lethal "Liaisons" during Cancer Progression. | Crit Rev Oncog | 2016 | https://conductscience.org/library/papers/27915969 | PubMed |
| 2 | 32201025 | ROS and oncogenesis with special reference to EMT and stemness. | Eur J Cell Biol | 2020 | https://conductscience.org/library/papers/32201025 | PubMed |
| 3 | 22666258 | Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison. | Int J Cell Biol | 2012 | https://conductscience.org/library/papers/22666258 | PubMed |
| 4 | 17899367 | Alteration of expression levels of the oxidative phosphorylation system (OXPHOS) in breast cancer cell mitochondria. | Breast Cancer Res Treat | 2008 | https://conductscience.org/library/papers/17899367 | PubMed |
| 5 | 12727897 | Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. | Genome Res | 2003 | https://conductscience.org/library/papers/12727897 | PubMed |
| 6 | 30128822 | NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways. | Breast Cancer Res Treat | 2018 | https://conductscience.org/library/papers/30128822 | PubMed |
| 7 | 32934344 | OXPHOS-dependent metabolic reprogramming prompts metastatic potential of breast cancer cells under osteogenic differentiation. | Br J Cancer | 2020 | https://conductscience.org/library/papers/32934344 | PubMed |
| 8 | 25792083 | Warburg effect or reverse Warburg effect? A review of cancer metabolism. | Oncol Res Treat | 2015 | https://conductscience.org/library/papers/25792083 | PubMed |
| 9 | 35589677 | TGF-β1/SH2B3 axis regulates anoikis resistance and EMT of lung cancer cells by modulating JAK2/STAT3 and SHP2/Grb2 signaling pathways. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35589677 | PubMed |
| 10 | 28625484 | Nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) is regulated by O-GlcNAc transferase. | Free Radic Biol Med | 2017 | https://conductscience.org/library/papers/28625484 | PubMed |
| 11 | 34679746 | Differential Yet Integral Contributions of Nrf1 and Nrf2 in the Human HepG2 Cells on Antioxidant Cytoprotective Response against Tert-Butylhydroquinone as a Pro-Oxidative Stressor. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/34679746 | PubMed |
| 12 | 28677688 | Mitochondria on the move: emerging paradigms of organelle trafficking in tumour plasticity and metastasis. | Br J Cancer | 2017 | https://conductscience.org/library/papers/28677688 | PubMed |
| 13 | 35858425 | Mitochondrial genome undergoes de novo DNA methylation that protects mtDNA against oxidative damage during the peri-implantation window. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/35858425 | PubMed |
| 14 | 21746850 | Signal transduction by reactive oxygen species. | J Cell Biol | 2011 | https://conductscience.org/library/papers/21746850 | PubMed |
| 15 | 19478820 | Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? | Nat Rev Drug Discov | 2009 | https://conductscience.org/library/papers/19478820 | PubMed |
| 16 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 17 | 20139083 | Metabolomic changes accompanying transformation and acquisition of metastatic potential in a syngeneic mouse mammary tumor model. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20139083 | PubMed |
| 18 | 16001073 | Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. | Nature | 2005 | https://conductscience.org/library/papers/16001073 | PubMed |
| 19 | 15525513 | A common set of gene regulatory networks links metabolism and growth inhibition. | Mol Cell | 2004 | https://conductscience.org/library/papers/15525513 | PubMed |
| 20 | 22000009 | Tumor metastasis: molecular insights and evolving paradigms. | Cell | 2011 | https://conductscience.org/library/papers/22000009 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42674824 | EPS8 Differentially Regulates Antioxidant Defense and Mitochondrial Homeostatic Signaling in LNCaP and Enzalutamide-resistant LNCaP Cells. | Cancer Genomics Proteomics | 2026 | https://conductscience.org/library/papers/42674824 | PubMed |
| 42373226 | NRF1 Activates the AMPK/SIRT1/PGC-1α/TFAM Axis to Suppress EMT and Tumor Progression in Lung Adenocarcinoma. | Cancer Genomics Proteomics | 2026 | https://conductscience.org/library/papers/42373226 | PubMed |
| 41899413 | Mitochondrial Long Non-Coding RNAs in Gynecological Cancers: Pathogenic Signaling Pathways and Therapeutic Opportunities. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41899413 | PubMed |
| 41872157 | AATF supports proliferation of glioblastoma cells by sustaining mitochondrial respiration through an NRF-1-dependent mechanism. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41872157 | PubMed |
| 41151855 | Rutin Suppresses EMT and Induces Mitochondrial Biogenesis via ER Stress-linked AMPK/SIRT1 Signaling in Prostate Cancer Cells. | Cancer Genomics Proteomics | 2025 | https://conductscience.org/library/papers/41151855 | PubMed |
| 41103963 | MDA-MB-231 breast cancer cells adapted to anchorage-independent growth reveal senescent-like phenotype and persistent downregulation of PD-L1 expression. | Front Oncol | 2025 | https://conductscience.org/library/papers/41103963 | PubMed |
| 41003771 | Mitochondrial stress response in lung cells triggered by the inhaled nanoplastics. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/41003771 | PubMed |
| 40989573 | Free Radicals in Health and Disease. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40989573 | PubMed |
| 40746900 | The impact of oxidative stress and the NRF2-KEAP1-ARE signaling pathway on anticancer drug resistance. | Oncol Res | 2025 | https://conductscience.org/library/papers/40746900 | PubMed |
| 40294841 | Anoikis resistance in Cancer: Mechanisms, therapeutic strategies, potential targets, and models for enhanced understanding. | Cancer Lett | 2025 | https://conductscience.org/library/papers/40294841 | PubMed |
| 39380996 | Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models. | Front Immunol | 2024 | https://conductscience.org/library/papers/39380996 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BLNK | 29760 | PubTator's text mining | https://conductscience.org/library/genes/29760 | NCBI Gene |
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| GPX1 | 2876 | PubTator's text mining | https://conductscience.org/library/genes/2876 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| NRF1 | 4899 | PubTator's text mining | https://conductscience.org/library/genes/4899 | NCBI Gene |
| PPARGC1A | 10891 | PubTator's text mining | https://conductscience.org/library/genes/10891 | NCBI Gene |
| RPL19 | 6143 | PubTator's text mining | https://conductscience.org/library/genes/6143 | NCBI Gene |
| SOD2 | 6648 | PubTator's text mining | https://conductscience.org/library/genes/6648 | NCBI Gene |
| SOX2 | 6657 | PubTator's text mining | https://conductscience.org/library/genes/6657 | NCBI Gene |
| VIM | 7431 | PubTator's text mining | https://conductscience.org/library/genes/7431 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36960492
GET https://conductscience.org/api/papers/v1/36960492/references?page=2